Fosun Pharmaceuticals announced that the 2025 A-share equity distribution plan was reviewed and approved by the 2025 Annual Shareholders' Meeting held on June 16, 2026. The equity distribution is based on the total share capital after deducting 2,639,554,073 shares that have been repurchased but not cancelled. A cash dividend of 0.39 yuan is distributed per share. A total of 1,029 million yuan is expected to be distributed, of which 818 million yuan will be distributed for A-shares. The share registration date is July 24, 2026, and the exclusion date and cash dividend payment date are July 27.

Fosun Pharmaceuticals announced that the 2025 A-share equity distribution plan was reviewed and approved by the 2025 Annual Shareholders' Meeting held on June 16, 2026. The equity distribution is based on the total share capital after deducting 2,639,554,073 shares that have been repurchased but not cancelled. A cash dividend of 0.39 yuan is distributed per share. A total of 1,029 million yuan is expected to be distributed, of which 818 million yuan will be distributed for A-shares. The share registration date is July 24, 2026, and the exclusion date and cash dividend payment date are July 27.